General Study Documents
Investigational Product
Oversight
Event Reporting and Safety
Staff Training and Qualifications
100

Documents that individually and collectively permit evaluation of the conduct of a trial and the quality of the data produced.

What are Essential Documents?

100

According to ICH-GCP, who is responsible for verifying that storage times and conditions for Investigational Medicinal Product (IMP) are acceptable?

The monitor/sponsor

100

IRB continuing review of a greater than minimal risk approved protocol that is currently enrolling subjects must happen__________.

At least annually

100

__________ can be unintended, unanticipated or intentional departure from the procedures or process approved by the sponsor and IRB

Protocol deviations

100

How often does the CV for study staff need to be updated, signed, and documented? 

2 years

200

The PI or research coordinator must advise a subject about the potential benefits, risks, and alternatives involved in any research procedures or treatment and document this on the _____________.

Informed Consent Form (ICF)

200

What is the KEY document  used to confirm the expectedness of an Adverse Event (AE) or Adverse Drug Reaction (ADR)

Investigator's Brochure

200

Used to log sponsor’s interim site monitoring visits, usually with the purpose of performing source data verification and review

What is the Monitoring Log?


200

Accurate reporting of adverse events is most important for__________

Subject Safety

200

The PI assigns duties based on education, experience, and training; this information is documented on the _______.

Delegation of Authority Log

300

Describes the study aims, research design, all study-related activities and procedures.

What is the Study Protocol?

300

This document is used to capture lot numbers, expiration dates, dates returned, amount dispensed, and more.

 

What is a Drug Accountability Log?

300

Who is responsible for oversight of a clinical trial at a study site?

Principal Investigator

300

Any untoward or unfavorable medical occurrence in a human study subject 

What are Adverse Events?

300

CITI GCP training must be renewed every____ years, and Human Subject Research (HSR) every ____ years

3  and 5

400

Original documents (or commonly known as certified true copies), data, and records where information is first captured (e.g: medical records, clinical and office charts, laboratory notes, etc.)

What are Source Documents?

400

According to ICH GCP who is responsible for the destruction of Investigational Product(s)?

Pharmacist, PI or Sponsor

The sponsor

400

Can be conducted internally or periodically by a sponsor to verify that the conduct of the trial is in compliance with the currently approved protocol/amendment(s), with GCP, and with applicable regulatory requirement(s).

What is a monitoring visit?

400

Events that result in death or life-threatening situations (may require hospitalization)

 Serious Adverse Event

400

Used to document all training completed by site study staff members that is not otherwise documented by a training completion certificate.

Training log

500

 Detailed written instructions that ensure the uniform performance of a specific function.

What are Standard Operating Procedures (SOP)?

500

The ________ includes details and directions that  the pharmacy and PI need to prescribe a drug properly, including approved uses for the drug, contraindications, potential adverse reactions, available formulations and dosage, and administration instructions 

Product Insert

500

_______ subjects include children, pregnant women, and prisoners.

Vulnerable 

500

What is the timeline for an investigator to report an SAE to a sponsor? 

7 days working days, 24hrs, immediately or at the next monitoring visit


 Immediately

500

All investigators and sub-investigators must be added to this form for IND/IDE studies.

A ___ form is a binding legal contract between the Principal Investigator (PI), the trial's sponsor, and FDA.

What is a 1572?